Share on StockTwits

Syneron Medical (NASDAQ:ELOS) released its earnings data on Wednesday. The company reported $0.07 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.07, American Banking and Market News reports. The company had revenue of $64.60 million for the quarter, compared to the consensus estimate of $63.52 million.

On a related note, analysts at Leerink Swann cut their price target on shares of Syneron Medical from $17.00 to $16.00 in a research note on Friday, May 16th.

Shares of Syneron Medical (NASDAQ:ELOS) opened at 10.06 on Wednesday. Syneron Medical has a 52-week low of $8.04 and a 52-week high of $13.32. The stock has a 50-day moving average of $10.23 and a 200-day moving average of $11.00. The company has a market cap of $368.7 million and a P/E ratio of 126.49.

Syneron Medical Ltd. designs, develops and markets aesthetic medical products based on its various technologies including its Electro-Optical Synergy (NASDAQ:ELOS), technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.